Overview

Dr. Bharadhan Somu is a dynamic and detail-oriented infectious diseases physician. He has proven expertise in the management of complex infections in various cohorts, including transplant recipients, oncology cases, and HIV-positive individuals. Dedicated to patient-centered care and institutional quality improvement, he is skilled in antimicrobial stewardship, hospital infection control, critical care, and public health.

Education

DM, Infectious Diseases (2019 – 2025) – All India Institute of Medical Sciences (AIIMS), New Delhi

MBBS (2011 – 2016) – Sri Ramachandra Medical College & Research Institute, Chennai

Areas of Expertise

Immunocompromised Host Infection Management

Antimicrobial Stewardship & Resistance Mitigation

Tropical Parasitology & Serological Diagnostics

Molecular & Microscopy-Based Diagnostics (PCR, ELISA, Culture)

Infection Control in Hospital & Oncology Settings

Clinical Experience

Senior Resident, Infectious Diseases All India Institute of Medical Sciences, New Delhi (2022 – Present)

Managed inpatient and outpatient cases involving TB, HIV, sepsis, fungal infections, and post-transplant complications.

Led consultations for critical care and oncology departments for antimicrobial optimization.

Contributed to COVID-19 care protocol revisions and supervised infection prevention teams.

Junior Resident, DM Infectious Diseases AIIMS, New Delhi (2019 – 2022)

Hands-on care for over 2000 patients with infectious and immunologic comorbidities.

Supported surveillance and outbreak response units during the COVID-19 pandemic.

Certifications

ACLS & BLS Certified – AIIMS, 2023

Certified in hospital infection prevention & isolation protocol implementation.

Diagnostics: PCR, ELISA, microscopy, agar culture, AST.

Clinical Tools: Hospital EMR, ICU monitoring, ventilator support systems.

Research & Publications

Completed Theses on:

Prevalence of Strongyloides Infection Among Immunocompromised Patients (AIIMS, 2024): A cross-sectional study proposing serologic screening prior to immunosuppression due to the low sensitivity of conventional diagnostics (found 13.81% seroprevalence with no positive stool or culture results).

Prevalence of Parvo B19 Virus in Hematological Disorders (AIIMS, 2022): Investigated B19 infection in patients with unexplained anemia and bone marrow suppression, highlighting the role of viral screening in hematologic workups.